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Abstract
Background: Sedentary behaviour (SB) has been identified as an important mortality risk factor. Health
organizations have recognised SB as a public health challenge with major health, social, and economic
consequences. Researchers have alerted the need to develop specific strategies, to monitor, prevent, and reduce SB.
However, there is no systematic analysis of the SB changes in European Union adults. We aimed to examine SB
changes between 2002 and 2017 in the European Union (EU) adult population.
Methods: SB prevalence (>4h30mins of sitting time/day) of 96,004 adults as a whole sample and country-by-
country was analysed in 2002, 2005, 2013, and 2017 of the Sport and Physical Activity EU Special Eurobarometers’
data. The SB question of a modified version of the International Physical Activity Questionnaire was considered. SB
prevalence between countries and within years was analysed with a χ2 test, and SB between genders was analysed
with the Z-Score test for two population proportions.
Results: An association between the SB prevalence and the years was found (p < 0.001), with increases for the
whole sample (2002: 49.3%, 48.5–50.0 95% confidence interval (CI); 2017: 54.5%, 53.9–55.0 95% CI) and men (2002:
51.2%, 50.0–52.4 95% CI; 2017: 55.8%, 55.0–56.7 95% CI) and women (2002: 47.6%, 46.6–48.7 95% CI; 2017: 53.4%,
52.6–54.1 95% CI) separately. The adjusted standardised residuals showed an increase in the observed prevalence
versus the expected during 2013 and 2017 for the whole sample and women and during 2017 for men. For all
years, differences were observed in the SB prevalence between countries for the whole sample, and men and
women separately (p < 0.001). Besides, the SB prevalence was always higher in men versus women in the overall
EU sample (p < 0.001).
Conclusions: SB prevalence increased between 2002 and 2017 for the EU as a whole and for both sexes separately.
Additionally, differences in SB prevalence were observed for all years between EU countries in the whole sample
and both sexes separately. Lastly, SB was consistently higher in men than women. These findings reveal a limited
impact of current policies and interventions to tackle SB at the EU population level.
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Background
Sedentary behaviour (SB) is defined as any waking be-
haviour characterised by an energy expenditure ≤1.5
metabolic equivalents (METs), while in a sitting, reclin-
ing, or lying posture [1]. SB has increased in the indus-
trialised countries in the last decades, with the average
adult spending more than half of the day in a SB [2].
This negative lifestyle change presents a major risk fac-
tor in the development of many chronic diseases such as
obesity, type 2 diabetes, hypertension, cancers, and even
premature death [2–5]. In this regard, SB is one of the
most important causes of death in developed countries
[6]. In European countries, the proportion of deaths at-
tributable to sitting time, a general proxy for SB, is 4.4%,
or more than 230,000 deaths/year [7]. Considering this,
SB has come to be a major health threat in modern soci-
ety [8], and awareness of the health and economic bur-
den of SB to policymakers is, therefore, paramount. Men
are more frequently sedentary than women [9–11], and
independently of the physical activity (PA) performed,
SB has negative consequences when sustained for long
uninterrupted periods of time [2, 12–14].
The promotion of PA has received substantial and in-
creasing attention globally, with myriad recommendations
and plans in circulation [15–17]. By comparison, SB has
received limited attention [18]. Previous studies showed
that complying with the global recommendations of PA
was insufficient to eliminate the increased risk of prema-
ture death as a consequence of a high SB (e.g., number of
sitting hours) [3, 19], unless the PA occurs at a consider-
able volume [3, 19], which is difficult to achieve for most
of the population. Moreover, Patterson et al. [5] report
that the risk of chronic disease associated with SB is not
reduced regardless of meeting the recommended PA
guidelines. As a consequence, a separate, but equally im-
portant focus is required on interventions that help reduce
or break-up SB and on public health policy to drive
change in SB at a population level [19].
Given the scale of the problem, the World Health
Organization (WHO) released a report in 2002, in which
it requested countries to develop population-level health
promotion strategies to reduce high levels of physical in-
activity and sedentary lifestyle. However, there was only
a recommendation addressing SB and no specific targets,
strategies, or key performance indicators [20].
Since 2002, systematic surveys have been administered
to the European Union (EU) member states to monitor
SB prevalence with self-report data gathered from the
International Questionnaire of Physical Activity (IPAQ)
short form. Several studies have analysed SB in these
Eurobarometers in a particular year (e.g., 2002 [21],
2005 [9], and 2013 [10, 22]), or as trend data between
years [23, 24]. Milton et al., [24] suggested that SB de-
creased across the EU from 2002 to 2013, while Jelsma
et al. (2019) reported that SB was relatively stable over a
15-year period. However, the implication of this time
trend analysis was limited by a change in the sitting
question included in the Eurobarometer survey between
2005 and 2013 [23, 24]. Each of these studies used the
same criteria to determine SB (i.e., >7h30mins), which is
typically considered a ‘high’ amount of SB. Therefore, in-
dividuals with middle amounts of daily SB (4h31min-
7h30mins) were not included. Milton et al. (2015) data
showed that merging these two groups increased SB
from 51.9% in 2002 to 53% in 2013 [24]. From a public
health perspective, it is essential to consider individuals
already exceeding 4h30min per day as that is the ac-
cepted cut-point resulting in an increased risk of having
cardiovascular diseases [25–27] or suffering cardiovascu-
lar disease mortality events [28].
With this in mind, is paramount to understand the im-
portance of trends in SB across the EU during the last
15 years, including those who exceed 4h30min/day. Fur-
thermore, data is required to determine the plausible im-
pact of policy development on SB behaviour between
those years [29, 30]. This is especially relevant since,
through the WHO’s Global Action Plans, it is continued
to emphasise the need for strengthening the systems re-
quired to implement effective and coordinated actions
aiming to reduce SB [16, 17]. A global understanding of
SB trends would inform new and update existing policy
and position statements in alignment with the recom-
mendations in the global action plan [16, 17].
The primary aim of this study was to identify changes
in SB between 2002 and 2017 in EU adults, analysing
four separate Sport and Physical Activity Eurobarom-
eter’s data. For this, we analysed the SB prevalence
(>4h30mins of sitting time/day), considering the
between-country differences for all years and the
changes within-country between years for the total sam-
ple and split by gender. The likely changes were com-
pared against the EU countries’ plans to prevent or
reduce SB.
Methods
Data source
The European Commission conducts public opinion sur-
veys simultaneously on all EU state members to inquire
about the levels of PA, sports participation, and SB among
its citizens. These surveys were conducted in 2002, 2005,
2013, and 2017 through the Sport and Physical Activity
and Health and Food Special Eurobarometer’s.
For this study, data were obtained from the adult
European population (18–99 years old) of four successive
Eurobarometer surveys; December 2002 (Special Euroba-
rometer 183.6; n = 15,363), December 2005 (Special
Eurobarometer 246; n = 26,413), December 2013 (Special
Eurobarometer 412; n = 26,988), and December 2017
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(Special Eurobarometer 472; n = 27,240), with a final
sample of n = 96,004 (42,546 men and 53,458 women)
from the 28 European Union member countries
(Austria, Belgium, Bulgaria, Czech Republic, Croatia,
Cyprus Republic, Denmark, Estonia, Finland, France,
Germany [combined West and East Deutschland], Great
Britain, Greece, Hungary, Ireland, Italy, Latvia, Lithuania,
Luxembourg, Malta, Netherlands, Poland, Portugal,
Romania, Slovakia, Slovenia, Spain, and Sweden). Data
from Northern Cyprus and Turkey were not analysed
because they do not belong to the EU member countries.
Northern Ireland was also not considered due to its
unique characteristics.
Eurobarometers use a multi-stage sampling design
where primary sampling units are selected from each of
the administrative regions in every country. The primary
sampling unit’s selection is proportional to the popula-
tion size of every country, from sampling frames strati-
fied by the degree of urbanization. In this regard,
gender, age, region, and the size of the locality were in-
troduced in the iteration procedure. All interviews are
conducted face-to-face in people’s homes in their na-
tional language [31, 32].
Measures
The IPAQ is a valid and reliable questionnaire to obtain
data on SB [33]. In addition to light, moderate, and vig-
orous PA, the IPAQ short-form records the total time
sitting on an average day as a proxy for SB (i.e., How
much time do you spend sitting on a usual day? This
may include time spent at a desk, visiting friends, study-
ing or watching television?). In the 2002 and 2005 sur-
veys, EU citizens were asked to estimate their usual
weekday sitting time using an open-ended response
scale. For the 2013 and 2017 surveys, EU citizens were
given a choice of 11 categorical response options, ran-
ging from ‘≤ 60 mins’ to ‘>8h30mins’. For this study, to
establish a standard measure of SB prevalence in the EU
adult population, a cut-off point of 4 h and 30 min was
used to define SB (i.e., from ‘>4h30mins’ to ‘>
8h30mins’), as these values show a higher risk of death
due to cardiovascular diseases [3, 28]. Furthermore, the
close answers in 2013 and 2017 in Eurobarometers did
not allow for calculating time spent in SB in relation to
other epidemiologic studies, so levels of SB were adapted
to these particular categories (i.e., ‘>4h30mins’ and be-
yond), as Milton et al. (2015) [24]. Individuals answering
‘don’t know’ were included in the analysis.
Statistical analysis
Descriptive statistics presented as a proportion (%) with
the 95% confidence interval (95% CI) were calculated for
the SB variable. The SB prevalence within EU countries,
for the entire sample and separately for gender and age
group (18–24, 25–34, 35–44, 45–54, 55–64, and 65 years
and older) were analysed with a χ2 test for 2002, 2005,
2013, and 2017. Additionally, the χ2 test was imple-
mented for comparing behaviour (SB, no-SB, or ‘don’t
know’) and years (2002, 2005, 2013, and 2017) along
with the analysis of the adjusted standardised residuals.
Furthermore, the within-country and within-year differ-
ences by gender in SB were analysed using a Z-Score for
two population proportions. A priori alpha level was set
at 0.05. Z-score analyses were performed with Microsoft
Excel version 1709 (Microsoft Corporation; Redmond,
Washington, United States of America). Remaining ana-
lyses were performed using the Statistical Package for
Social Sciences (version 22.0, SPSS Inc., Chicago, IL,
USA).
Results
Significant differences in the prevalence of SB between
countries for the entire country sample were observed in
2002 (n = 15,363; χ2 = 791.963; DF = 28; p < 0.001), 2005
(n = 26,413; χ2 = 1990,145; DF = 54; p < 0.001), 2013
(n = 26,988; χ2 = 1744,015; DF = 52; p < 0.001) and 2017
(n = 27,240; χ2 = 1488,979; DF = 52; p < 0.001). Similarly,
significant differences between countries were also ob-
served for men in 2002 (n = 7082; χ2 = 381,420; DF = 28;
p < 0.001), 2005 (n = 11,286; χ2 = 1111,757; DF = 54;
p < 0.001), 2013 (n = 12,063; χ2 = 828,192; DF = 52; p <
0.001) and 2017 (n = 12,115; χ2 = 777,311; DF = 52; p <
0.001); and women in 2002 (n = 8281; χ2 = 441,942; DF =
28; p < 0.001), 2005 (n = 15,127; χ2 = 1057,698; DF = 54;
p < 0.001), 2013 (n = 14,925; χ2 = 1005,487; DF = 52;
p < 0.001) and 2017 (n = 15,125; χ2 = 79,778; DF = 52;
p < 0.001). Descriptive characteristics of the sample can
be found in Table 1.
An association between the prevalence of SB and the
years were found for the whole sample (n = 96,004; χ2 =
727,982; DF = 6; p < 0.001). These associations were also
found for men (n = 42,546; χ2 = 307,233; DF = 6; p <
0.001) and women (n = 53,458; χ2 = 423,673; DF = 6;
p < 0.001) separately. As is reflected in Fig. 1, over the
15 year-period in the EU member countries, the adjusted
standardized residuals showed an increase in the preva-
lence observed versus the expected during 2013 and
2017 for the whole sample (adjusted standardized resid-
uals = 2.9 and 13.1) and women (adjusted standardized
residuals = 3.1 and 9.8), but only during 2017 for men
(adjusted standardized residuals = 8.7). This trend was
similar for each of the age groups analysed. Significant
differences in the prevalence of SB between age groups
for 2002 (χ2 = 179,189; DF = 10; p < 0.001), 2005 (χ2 =
289,434; DF = 10; p < 0.001), 2013 (χ2 = 184,806; DF =
10; p < 0.001) and 2017 (χ2 = 161,136; DF = 10; p <
0.001) were observed. The SB prevalence for 18–24 and
65 years and older age groups was higher than the
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expected for all years. Likewise, there were significant dif-
ferences within age group between years (p < 0.001)
(Table 2). However, SB prevalence was higher than the ex-
pected only for 2013 and 2017 in 35–44 age group, and
2017 in 45–54, 55–64 and 65 years and older age groups.
In 2004, the number of EU countries increased from
15 to 28. Therefore, an additional analysis was per-
formed only considering the first 15 countries. For this
group of countries, an association between SB preva-
lence and the years were found for the whole sample
(n = 60,325; χ2 = 661,052; DF = 6; p < 0.001). The ana-
lysis of the residuals showed an increase in the preva-
lence of SB observed versus the expected during 2013
and 2017 (adjusted standardised residuals = 4.5 and
12.3). These differences were also found for men (n =
28,060; χ2 = 333,673; DF = 6; p < 0.001) and women
(n = 32,265; χ2 = 329,483; DF = 6; p < 0.001) separately.
An increase was also reported in the prevalence of SB
observed versus the expected during 2013 and 2017 for
men (adjusted standardised residuals = 3.2 and 8.2) and
women (adjusted standardised residuals = 3.1 and 9.0).
All the countries showed changes in SB prevalence be-
tween years (Table 2), with most of them showing an
observed higher prevalence in 2017 than the expected
(i.e., Austria, Belgium, Bulgaria, Estonia, France,
Germany, Great Britain, Greece, Hungary, Italy, Ireland,
Lithuania, Malta, Portugal, Romania, Slovakia, Slovenia,
Sweden, and The Netherlands). Only Finland showed
fewer observed cases than the expected for 2017.
While considering the subsamples of men and women
separately for every country, and as can be observed in
Table 3, similar patterns are generally reported. Differ-
ences between years were observed for most of the coun-
tries except for men in Croatia. The SB prevalence
observed in 2017 was higher than the expected for men in
Austria, Germany, Great Britain, Hungary, Ireland,
Lithuania, Portugal, Romania, Slovakia, Sweden, and The
Netherland. For women, the increase in the cases reported
versus the expected was observed for Belgium, Bulgaria,
France, Greece, Hungary, Italy, Ireland, Malta, Portugal,
Romania, Slovenia, Sweden, and The Netherland.
When analysing gender differences (Table 3), SB
prevalence in the overall EU sample was significantly
higher in men compared to women for the whole sam-
ple. Almost all countries displayed greater SB prevalence
in men in comparison with women over the years, with
the following exceptions showing higher levels of SB
prevalence in women in 2002 (Germany, Denmark,
Ireland, and Spain), 2005 (Austria, Bulgaria, Estonia,
Greece, Hungary, Latvia, Lithuania, Poland, and
Slovakia), 2013 (Austria, Bulgaria, Estonia, Hungary,
Latvia, Lithuania, Poland, Romania, and Sweden), and
2017 (Belgium, Bulgaria, Czech Republic, Estonia,
Greece, Hungary, Italy, Latvia, Lithuania, Slovenia, and
Sweden). Only five countries have shown a greater SB
prevalence in women versus men for all the years
(Bulgaria, Estonia, Hungary, Latvia, and Lithuania).
Discussion
The main findings were that (a) there was a recurrent
difference between countries for all years, indicating that
there is a dissimilar capability to prevent or reduce the
prevalence of SB across the EU; (b), there was an in-
crease in SB prevalence in the European adults from
2005 to 2017 considering the whole sample and men
and women separately; and (c) there was a generally
higher prevalence of SB in men than women, with a
similar descriptive trend from 2005 to 2017.
Previous studies have reported that SB was rather
stable over the 15-year period [23], or even declined
based on 2002, 2005, and 2013 Eurobarometer data [24].
Table 1 Descriptive characteristics of the sample
Sample Overall 2002 2005 2013 2017
N Age N Age N Age N Age N Age
Total 96,004 50 ± 18 15,363 46 ± 18 26,413 48 ± 18 26,988 50 ± 18 27,240 52 ± 18
Men 42,546 50 ± 18 7082 46 ± 17 11,286 46 ± 18 12,063 50 ± 18 12,115 52 ± 18
Women 53,458 50 ± 18 8281 46 ± 18 15,127 49 ± 18 14,925 50 ± 17 15,125 52 ± 18
Fig. 1 Prevalence (%) of sedentary behaviour (>4h30min/day) in
European Union adults (in squares, the men sample; in circles, the
whole sample; and in triangles, the women sample) for 2002, 2005,
2013, and 2017. Data are means ± CI. Analysis of the adjusted
standardised residuals: *Higher observed prevalence of sedentary
behaviour than the expected for the group “>4h30min”
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Nevertheless, there is an important difference to con-
sider when comparing our data with the findings of the
previous studies. Jelsma et al. (2019) [23] analysed only
the percentages of population with more than 7h30mins
per day of SB, while Milton et al. (2015) established con-
clusions with the data of the high sitting group (>
7h30min) when the middle sitting group (> 4 h31 to 7
h30min) was not included in the analysis [24]. When
considering the 4h30min group, there exists a trend of
increasing SB prevalence over the years, similarly to
ours. This discrepancy is very relevant to consider when
analysing the information provided by each of these
studies since it could lead to different outcomes. In our
opinion, considering individuals with >4h30mins is per-
tinent because different studies have already shown an
increased risk of suffering cardiovascular diseases and
Table 2 Prevalence (%) of sedentary behaviour (>4h30min/day) in European Union (EU) countries adults between 2002 and 2017
Sample 2002 2005 2013 2017 2002–2017
Sample SB (%) 95% CI Sample SB (%) 95% CI Sample SB (%) 95% CI Sample SB (%) 95% CI χ2 p-value
EUc,d n = 15,363 49.3 48.4–50.1 n = 26,413 47.7 47.1–48.3 n = 26,988 51.6 51.0–52.2 n = 27,240 54.3 53.7–54.9 683,096 < 0.001
Age Group
18–24 n = 1841 57.3 55.0–59.7 n = 2642 60.1 58.2–62.0 n = 2238 57.5 55.5–59.6 n = 1842 58.0 55.5–60.2 53,100 < 0.001
25-34d n = 2758 47.0 45.2–48.8 n = 4185 47.5 46.1–49.0 n = 3793 48.9 47.1–50.4 n = 3503 50.5 48.9–52.2 98,418 < 0.001
35-44c,d n = 2996 43.7 41.9–45.5 n = 4828 43.6 42.2–45.0 n = 4467 48.1 46.7–49.5 n = 4316 50.4 48.9–51.8 123,955 < 0.001
45-54d n = 2549 46.4 44.6–48.5 n = 4461 45.1 43.6–46.6 n = 4835 49.1 47.8–50.6 n = 4613 51.7 50.2–53.2 96,233 < 0.001
55-64d n = 2267 47.6 45.7–49.8 n = 4486 44.5 43.1–45.9 n = 5013 49.6 48.2–50.9 n = 5019 53.2 51.9–54.7 136,982 < 0.001
65 years and olderdn = 2952 55.8 54.1–57.5 n = 5811 50.2 48.9–51.5 n = 6642 56.8 55.6–57.9 n = 7947 59.4 58.3–60.4 266,122 < 0.001
Countries
Austriac,d n = 979 40.0 37.0–43.3 n = 981 55.4 52.4–58.4 n = 1006 59.2 56.0–62.1 n = 1011 63.1 59.9–66.1 276,263 < 0.001
Belgiumd n = 1065 47.8 44.7–50.8 n = 964 54.6 51.1–57.6 n = 1047 55.7 52.5–58.7 n = 985 58.7 55.7–61.6 193,779 < 0.001
Bulgariac,d n = 953 43.2 39.9–46.3 n = 1007 57.9 54.8–60.9 n = 1015 55.7 52.6–58.9 61,226 < 0.001
Croatiac n = 966 48.2 44.9–51.1 n = 992 55.1 52.1–58.3 n = 1018 51.2 47.9–54.3 9977 0.041
Cyprus n = 473 52.9 48.4–57.3 n = 483 52.0 47.6–56.3 n = 487 47.4 42.7–51.7 68,164 < 0.001
Czech Republic n = 995 58.0 55.1–61.2 n = 998 59.5 56.5–62.4 n = 1011 62.1 59.3–64.9 71,718 < 0.001
Denmarkc n = 988 67.1 64.1–69.9 n = 1011 63.6 60.5–66.7 n = 992 71.7 68.9–74.4 n = 996 67.3 64.3–70.4 52,219 < 0.001
Estoniad n = 955 52.0 49.0–55.3 n = 993 55.7 52.4–58.8 n = 986 60.8 57.9–63.8 43,981 < 0.001
Finlanda,c n = 977 61.4 58.5–64.6 n = 982 52.2 49.6–55.4 n = 954 61.5 58.2–64.5 n = 1008 53.0 50.0–55.9 48,861 < 0.001
Francec,d n = 1011 43.3 40.5–46.3 n = 986 40.7- 37.7–43.7 n = 1002 49.1 45.8–52.0 n = 991 51.0 47.6–54.2 66,148 < 0.001
Germanyd n = 1991 50.0 48.0–52.3 n = 1512 50.6 48.1–53.2 n = 1566 51.3 48.9–53.8 n = 1577 53.7 51.0–56.2 148,307 < 0.001
Great Britainc,d n = 984 43.5 40.2–46.9 n = 989 46.9 43.7–50.1 n = 975 56.4 53.3–59.5 n = 1015 53.3 50.3–56.2 166,157 < 0.001
Greeced n = 969 48.4 45.3–51.9 n = 979 69.8 66.9–72.8 n = 975 55.9 52.8–59.3 n = 979 63.7 60.6–66.4 121,256 < 0.001
Hungaryd n = 990 37.2 34.1–40.3 n = 997 38.8 35.9–41.8 n = 1033 46.7 43.6–49.5 31,043 < 0.001
Italya,d n = 995 53.7 50.8–56.7 n = 969 43.7 40.5–46.5 n = 1009 43.3 40.3–46.3 n = 1026 53.8 50.9–56.8 47,827 < 0.001
Irelandd n = 955 40.3 37.4–43.6 n = 968 37.9 34.8–40.9 n = 979 42.3 39.2–45.7 n = 985 47.7 44.7–50.8 143,304 < 0.001
Latviac n = 933 42.7 39.4–45.8 n = 979 50.8 47.8–53.8 n = 971 49.2 46.0–52.5 30,446 < 0.001
Lithuaniac,d n = 958 35.8 32.8–38.8 n = 980 51.9 48.8–55.0 n = 998 50.0 47.1–53.3 216,693 < 0.001
Maltad n = 483 29.0 25.3–33.3 n = 496 35.9 31.7–39.9 n = 500 47.2 42.6–51.6 91,250 < 0.001
Luxembourg n = 580 49.8 45.5–54.0 n = 472 48.1 43.6–52.5 n = 490 52.9 48.6–57.6 n = 485 52.4 47.8–56.9 33,608 < 0.001
Polandc n = 950 52.2 48.9–55.4 n = 986 43.4 40.5–46.7 n = 981 45.5 42.3–48.5 41,338 < 0.001
Portugald n = 949 31.0 28.0–33.9 n = 968 24.9 22.1–27.4 n = 1037 34.1 31.3–36.9 n = 1068 44.3 41.4–47.2 156,497 < 0.001
Romaniad n = 960 28.7 25.7–31.7 n = 987 36.0 32.9–39.1 n = 974 40.6 37.3–43.7 59,108 < 0.001
Slovakiad n = 1029 47.9 45.0–51.2 n = 979 55.3 51.9–58.2 n = 1086 56.7 53.9–59.7 63,072 < 0.001
Sloveniab,d n = 985 46.9 43.6–50.1 n = 1096 35.0 32.2–37.8 n = 1016 45.7 42.8–48.6 71,376 < 0.001
Spain n = 938 44.1 40.9–47.3 n = 987 41.0 38.0–44.0 n = 990 43.3 40.3–46.8 n = 1002 45.8 42.7–48.9 114,461 < 0.001
Swedenc,d n = 987 57.4 54.2–60.4 n = 1021 54.1 50.7–57.3 n = 991 65.7 62.7–68.7 n = 1034 67.8 64.9–70.9 81,934 < 0.001
The Netherlandsc,d n = 995 59.3 56.4–62.4 n = 994 67.5 64.7–70.6 n = 1002 73.7 70.9–76.2 n = 1002 79.9 77.4–82.4 171,853 < 0.001
CI Confidence intervals. Analysis of the adjusted standardised residuals: Higher observed cases than the expected on the >4h30min box for 2002 (a), 2005 (b),
2013 (c), and 2017 (d)
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premature death in people who accumulate more than 4
h daily of SB [3, 19]. While it is clear that increased
hours of SB results in worsening health outcomes, redu-
cing individual-level SB time, for all individuals, yields
the greatest overall public health benefit. For example,
as reducing sitting time by ~ 2 h/day results in a 2.3%
decrease in mortality [7].
This increase in the prevalence of SB could be ex-
plained by the social and environmental changes. For ex-
ample, longer work commute durations, a greater
number of labour-saving devices both at home and work
[34] and urban environment inequalities that force
people to travel longer distances and live in areas that
lack support for active lifestyles [35] could all be contrib-
uting to the increased SB time. Furthermore, work and
leisure-time are related to technology and consequently,
people of all ages are spending more time interacting
with technology in the form of Internet, videogames,
interactive television, mobile phones, etc. [36].
Policy development on SB prevention has received in-
creased attention in the last decade [18]. Some general
recommendations from national and international orga-
nisations began to emerge at the end of the 2000s for re-
ducing SB, such as the example the EU Physical Activity
Guidelines [37] or the Physical Activity and Health Re-
port from the U.S. [38], and most notably the World
Health Organization supporting evidence to action
through the Physical Activity and Health in Europe [39].
Policy-level interventions to reduce SB are, however, less
developed than those attempting to reduce population
levels of physical inactivity [40]. A previous analysis re-
view found that only 22% of PA guidelines mentioned
SB as part of a policy [41]. Besides, another study
showed that very few countries had documents related
to SB independently of PA policies [42]. This is despite
evidence that suggests SB has more influence on de-
creasing health outcomes compared to physical inactivity
[43]. In this sense, some countries may have more re-
cently developed SB policies. In contrast, others still do
not have any defined guidelines, aim, or even specific
surveillance and monitoring systems that could help re-
duce SB.
In line with early calls to introduce public health
guidelines on SB as soon as possible [44], some countries
have made attempts to develop a policy regarding SB
such as Belgium [45], France [46], Germany [47], Great
Britain [48, 49], Spain [50], Sweden [51], and the
Netherlands [52]. Still, a greater focus across all EU
countries is required. This needs to extend to include
appropriate surveillance and monitoring systems that as-
sess attempts to reduce SB as well as guidelines them-
selves. This has been identified recently [53], underlining
the importance of the evidence base when developing
prescriptive public health guidance on SB as once
established, and they are difficult to modify without gen-
erating confusion – as seen with the PA guidelines [54].
Regarding gender differences, results are consistent
with previous studies where the prevalence of SB was al-
ways higher in men than women [9, 23, 24, 55]. Previous
studies have shown that regarding gender, SB might be
context-dependent [22]. For example, highly educated
individuals spend more time sitting, which is still the
case for more men than women in some EU countries,
particularly those in Eastern Europe [9]. On the other
hand, older women have been shown to be less seden-
tary than older men, probably because they still spend
more time on household activities [56]. An alternative
explanation could be related to the pattern of SB, in
which women are more likely to accumulate their seden-
tary time in shorter bouts and, therefore, more likely to
break up prolonged periods of sitting than men [56].
The consistent finding of higher SB prevalence in men
should be an important point of consideration when dis-
cussing policy for SB reduction efforts.
Some limitations of this study should be recognised.
Firstly, methodological differences exist between 2002
and 2005 and 2013–2017 data collection, which was
solved using the same cut-points for each of the 4 years
data were collected. Secondly, SB was assessed using a
single recall item focused on one typical day, yet SB os-
cillates greatly from 1 day to another. Eurobarometer
data may, therefore, underestimate sitting time when
compared to an objective tool such as accelerometry,
which is the gold standard for SB [10, 57–59]. Lastly,
our study did not contemplate specific patterns of SB re-
garding breaking time of SB while standing, stretching,
or including light PA, which might have different effects
on the individuals.
Despite general efforts internationally to reduce SB,
current data make clear the need for strengthening exist-
ing policies and developing new ones to address SB
prevalence. Although numerous studies acknowledge the
hazards of excessive SB, there are very few specific SB
recommendations at a population level. Moreover,
guidelines should target SB independently of PA, with
specific goals and key performance indicators identified
to reduce SB [42]. SB is arguably an easier behaviour to
perform than PA, because no equipment is required, and
it can be as simple as a person standing. It has been ac-
knowledged that reducing SB is the first step on the
physical activity behavioral continuum [60], meaning
that changes to SB could also facilitate increases in PA
in the future. Policies would need to make clear to the
public how to reduce SB in tangible ways. Policies also
need to articulate the difference between SB and PA
clearly. Secondly, countries with SB defined policies
should assess and strengthen said policies, monitoring
surveillance data, and evaluating previous and ongoing
López-Valenciano et al. BMC Public Health         (2020) 20:1206 Page 8 of 10
interventions [16]. Countries without policies should de-
velop plans on SB, following current recommendations,
and learning from others that have shown even moder-
ate success [16, 42]. Finally, none of the EU countries
considered gender in their written policy, yet it is clear
that gender differences exist in the volume and pattern
of SB [56].
Conclusions
There were differences in SB prevalence between EU
countries for all the years when considering the whole
sample and for men and women separately, indicating
an unequal capacity for tackling sedentary behaviour in
the continent. Additionally, and considering the last 15
years of SB monitoring, an increase in SB for EU adults
was observed both as a whole and while considering
genders separately, indicating a limited impact of exist-
ing SB policy. Lastly, a generally higher SB prevalence in
men than women is usually reported, remaining consist-
ent over time. Futures analyses should be implemented
across EU with objective measures of SB.
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